📊 *Post-Market Snapshot (Feb 14, 2025)* 📈 *Indices:* 🔹 Nifty 50: 22,929 (-0.44%) | 🔹 Sensex: 75,939 (-0.26%) | 🔹 India VIX: 15.02 (+0.40%) 📌 *Sector Performance:* ❌ All sectors in red – Media (-3.40%), Pharma (-2.87%) led the decline. 📌 *Stock Movers:* 🚀 Top Gainers: Godfrey Phillips ₹5,999 (+20.0%), Triveni Turbine ₹588 (+3.96%) 📉 Top Loser: Concord Biotech ₹1,692 (-19.86%) 📰 *Key Updates:* 🔹 Godfrey Phillips (+20.0%) – Tobacco segment revenue +37% YoY to ₹1,875 crore, net profit ₹316 crore (+49% YoY). Exclusive Marlboro distributor in India. 🔹 Capacit’e Infraprojects (-6.82%) – Bags ₹1,320 crore NBCC order for Greater Noida residential project. 🔹 Glenmark (-6.25%) – Launches Latanoprost Ophthalmic Solution in the U.S., expanding ophthalmic portfolio. 🔹 Vodafone Idea (-4.98%) – Clarifies ₹10,000 crore capex for FY25, with ₹5,300 crore spent till Dec 2024. 🔹 NBCC (-4.24%) – Secures ₹851.69 crore work orders, including ₹776.75 crore for DVC township projects. 🔹 Premier Energies (-3.84%) – Gets ₹1,234 crore order for solar module supply, deliveries from April 2025. 🚀 Markets ended lower with broad-based declines.